Choosing Wisely for young women with breast cancer: Medical therapy

ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer

Immunotherapy resistance pathways investigated to tailor combination NSCLC therapy

ESMO 2024: Latest in EGFR mutated NSCLC

Improved structure preservation with neo-adjuvant platinum-based chemo in patients with resectable NPNSCC

Breastfeeding after breast cancer is safe

Repeat immune checkpoint inhibitor therapy not recommended for aRCC

Association of adult attachment with delays in accessing specialist care in women with ovarian cancer

Multiple myeloma In Rwanda: The need for further research

Addressing the rise of multiple myeloma in Rwanda

Intervention of osteoclastogenesis that occurs in breast cancer and multiple myeloma

A patient-reported questionnaire may eliminate the need for an ophthalmic exam before belantamab mafodotin dosing in TI NDMM